Founded
Website
Recent investment activity
KANDO id: 127463
Company type
Developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function.Funding rounds
N/A
( )
| Investor | Profile | Country | |
|---|---|---|---|
|
Venrock Associates | The venture capital arm of the Rockefeller Family. |
| Investor | Profile | Country | |
|---|---|---|---|
|
ARCH Venture Partners LP | Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup | |
|
BayStar Capital | ||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Celera Corp | A healthcare company dedicated at first on sequencing human genome; now focused on therapeutics for cancer and other diseases | |
|
Chevron Technology Ventures LLC (CTV) | Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron | |
|
Comdisco Inc | ||
|
|
CW Group Inc | ||
|
Dow Venture Capital | The corporate venture capital unit of Dow Chemical Co | |
|
JPMorgan Chase & Co | ||
|
Oxford Bioscience Partners III LP | ||
|
|
Roche Holding Ltd |
Actual initial investment stage
Acquisition (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 5 of 5| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
|
Avantome | Acquisition Initial investment led the round | ||||
|
|
Helixis Inc | Medical equipment company that develops low-cost molecular diagnostic products. | Acquisition USD 105,000,000 (USD 105,000,000) | |||
|
|
Illumina Ventures I | Fund Closing | ||||
|
|
Nextbio | Acquisition led the round | ||||
|
Oxford Nanopore Technologies Ltd | Developing the GridION system, a new generation of technology that uses nanopores - very small holes created in electrically resistant membranes. | Venture Exited |